Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

[Preprint]. 2024 Jun 25:rs.3.rs-4492352. [Version 1] doi: 10.21203/rs.3.rs-4492352/v1

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This work is licensed under a Creative Commons Attribution 4.0 International License, which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.

PMC Copyright notice

Overview of study design and measurement timepoints

Patients who are interested in enrolling in the study complete a virtual screening to determine eligibility. Eligible participants are scheduled for an in-person blood draw at a Quest Laboratory location of their choice to confirm HbA1c eligibility requirements before participating in study activities. Prior to measurement timepoints, participants are mailed CGM sensors and a CGM reader. At each measurement timepoint, participants complete electronic questionnaires, wear a CGM sensor for 12 days, and visit a Quest Laboratory location for an in-person blood draw. After the baseline assessment, participants are randomized to one of three study intervention arms: UCC, Standardized, or Personalized.Additional measurements occur at 3 and 6 months.